Chem Tech Research Incorporation Report issue

For profit Phase 1 Phase 4
Founded: Des Moines IA United States (1979)
Status: Acquired by Neogen (2014)

Organization Overview

First Clinical Trial
2012
NCT01647893
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Chem Tech Research Incorporation

Active Ingredients

Drugs in Phase 4 Trials (1)

taltirelin tetrahydrate (1 trial)

Drugs in Phase 1 Trials (1)

ctb-001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ataxia (Phase 4)

Spinocerebellar Ataxias (Phase 4)

Spinocerebellar Degenerations (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2